This suggests that the added LBP binds to something, removing its effect, and here we suggest (i) that it is LPS that is present in the naïve T2D, which is known, and (ii) that it is this presence of the LPS that is in part responsible for the anomalous clotting in T2D plasma. The gene discussed is LBP; the disease is type 2 diabetes mellitus.